July 18, 2019
New Alexion Japan President Kimihiro Kasamo The Japan arm of Alexion Pharmaceuticals said on July 17 that Kimihiro Kasamo, MD, PhD, head of its metabolic disease business, will be promoted to its president, effective August 1, while retaining the current...read more